Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Inhibrx Biosciences Inc.
Sponsor

Inhibrx Biosciences Inc.

United States 11025 North Torrey Pines Road Suite 140, 92037-1030, United States

About the sponsor

Inhibrx Biosciences Inc. focuses on oncology programs for adults with advanced or metastatic solid tumors, including broader tumour settings where disease control and progression outcomes are central clinical concerns. Its portfolio includes studies across multiple solid tumor types and treatment combinations.

  • Solid tumor oncology
  • Metastatic cancer
  • Antitumor efficacy

Research activity in this area spans patients with difficult-to-treat malignancies and evaluation of therapeutic approaches intended to address tumour growth and disease progression.

About Specializations

Inhibrx Biosciences Inc. runs clinical trials in conditions such as Neoplasm, Squamous cell carcinoma of head and neck, Chondrosarcoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Neoplasm

Recruiting

Study of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Inhibrx Biosciences Inc.

Squamous cell carcinoma of head and neck

Not recruiting

Study of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Inhibrx Biosciences Inc.

Chondrosarcoma

Not recruiting

Study of INBRX-109 (ozekibart) compared to placebo in adults with unresectable or metastatic chondrosarcoma - a rare bone cancer

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetylcysteine
  • Sponsor:Inhibrx Biosciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.